86165 Augsburg, de
+49 (821) 79737-22
Till Reuter terminates his office as CEO in December in agreement with the supervisory board
Peter Mohnen takes over and ensures continuity
Dr. Till Reuter has been KUKA CEO for almost ten years. He joined the company in 2009 and led the company out of the economic crisis. Under his leadership the company kept its number one position in automotive and further diversified into new markets. Together with the KUKA team he shaped the strategy towards Industrie 4.0, collaborative robots and growth in China.
Dr. Till Reuter: “I am proud to have been part of KUKA for the last ten years and pushed robotics forward together with the team. Robotics and automation are the key topics of the future. I wish you all the best for the future. You always have my support. “
“We want to continue to be a reliable partner for our customers, based on the know-how of our employees”, said Peter Mohnen.
Dr. Andy Gu, Chairman of the Supervisory Board: “On behalf of the supervisory board and the entire company, I would like to thank Dr. Reuter for his tremendous efforts in successfully managing KUKA’s turnaround since he took the helm in 2009. KUKA is now well-positioned to re-enter a path of sustainable growth, benefiting from the increasing demand in intelligent robotics and by strengthen the position in the Chinese market. ”
All existing investor agreements that KUKA has signed with Midea as controlling shareholder including the ring-fencing-agreement protecting KUKA’s intellectual property will stay in place unchanged.
Midea expressed its support for KUKA’s growth strategy, including the development of the Chinese market, focus on research and development, investment in digitization and Industrie 4.0 as well as a strong commitment to KUKA´s presence in Germany.
The use of information published here for personal information and editorial processing is generally free of charge. Please clarify any copyright issues with the stated publisher before further use. In the event of publication, please send a specimen copy to email@example.com.